BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/17/2023 10:37:45 AM | Browse: 163 | Download: 587
 |
Received |
|
2022-11-29 11:08 |
 |
Peer-Review Started |
|
2022-11-29 11:09 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-02-14 03:50 |
 |
Revised |
|
2023-02-20 15:04 |
 |
Second Decision |
|
2023-03-03 03:21 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2023-03-03 08:29 |
 |
Articles in Press |
|
2023-03-03 08:29 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-03-09 07:03 |
 |
Publish the Manuscript Online |
|
2023-03-17 10:37 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Pediatrics |
Manuscript Type |
Case Report |
Article Title |
Acromicric dysplasia caused by a mutation of fibrillin 1 in a family: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ren Shen, Jian-Hua Feng and Shan-Pu Yang |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Shan-Pu Yang, MBChB, Chief Physician, Department of Pediatrics, The People's Hospital of Yuhuan, No. 18 Changle Road, Yucheng Street, Taizhou 317600, Zhejiang Province, China. ysp6005@qq.com |
Key Words |
Fibrillin 1; Gene; Acromicric dysplasia; Short stature; Recombinant human growth hormone; Case report |
Core Tip |
Acromicric dysplasia (AD) is a rare skeletal dysplasia, and its incidence is < 1 in 1000000. Here, we report a clinical phenotype of AD associated with mutations in the fibrillin 1 (OMIM 102370) gene c.5183C>T (p.Ala1728Val) in three people from a Chinese family. A 4-year-old boy was treated with recombinant human growth hormone (rhGH) for > 5 years. The efficacy of rhGH was clear in the first year of treatment; his height increased from -3.64 standard deviation score (SDS) to -2.88 SDS, while the efficacy weakened from the second year. However, long-term follow-up is required to clarify the efficacy of rhGH. |
Publish Date |
2023-03-17 10:37 |
Citation |
Shen R, Feng JH, Yang SP. Acromicric dysplasia caused by a mutation of fibrillin 1 in a family: A case report. World J Clin Cases 2023; 11(9): 2036-2042 |
URL |
https://www.wjgnet.com/2307-8960/full/v11/i9/2036.htm |
DOI |
https://dx.doi.org/10.12998/wjcc.v11.i9.2036 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345